Ubs Group Ag Novan, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.82 - $1.48 $5,446 - $9,830	-6,642 Reduced 99.63%	25 $0
Q3 2022 Nov 10, 2022	BUY	$1.76 - $3.03 $9,929 - $17,095	5,642 Added 550.44%	6,667 $13,000
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $4,094 - $8,280	-1,016 Reduced 49.78%	1,025 $4,000
Q3 2021 Nov 15, 2021	BUY	$7.48 - $10.17 $7,599 - $10,332	1,016 Added 99.12%	2,041 $16,000
Q2 2021 Aug 13, 2021	BUY	$7.8 - $17.35 $7,995 - $17,783	1,025 New	1,025 $10,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.